发明名称 CALCIUM CHANNEL BLOCKERS
摘要 Compounds of formula (1) wherein m is 0, 1 or 2; wherein when m is 0, Z is 0 ; when m is 1, Z is N, and when m is 2, Z is C; Y is H, OH, NH2, or an organic moiety of 1-20C, optionally additionally containing 1-8 heteroatoms selected from the group consisting of N, P, O, S and halo; each 11 and 12 is independently 0-5; 13 is 0 or 1; each of R1, R2 and R3 is independently alky l (1-6C), aryl (6-10C) or arylalkyl (7-16C) optionally containing 1-4 heteroatoms selected from the group consisting of halo, N, P, O, and S or ea ch of R1 and R2 may independently be halo, COOR, CONR2, CF3, CN or NO2, wherein R is H or lower alkyl (1-4C) or alkyl (1-6C); n is 0 or 1; X is a linker; with the proviso that Y is not a tropolone, a coumarin, or an antioxidant containing an aromatic group and with the further proviso that if 13 is 0, neither R1 nor R2 can represent F in the para position; and are useful as calcium channel blockers. Libraries of these compounds can also be used to identify antagonists for other targets.
申请公布号 CA2335461(A1) 申请公布日期 2000.01.13
申请号 CA19992335461 申请日期 1999.06.30
申请人 NEUROMED TECHNOLOGIES, INC. 发明人 SNUTCH, TERRANCE PRESTON;ZAMPONI, GERALD WERNER
分类号 C12Q1/02;A61K31/4427;A61K31/445;A61K31/4468;A61K31/451;A61K31/4515;A61K31/454;A61K31/4545;A61K31/495;A61K31/496;A61K31/498;A61K31/506;A61K31/535;A61K31/5375;A61K31/538;A61K31/5415;A61P9/00;A61P9/10;A61P9/12;A61P25/00;A61P25/04;A61P25/08;A61P29/00;A61P43/00;C07D211/14;C07D211/16;C07D211/46;C07D211/58;C07D239/42;C07D241/04;C07D295/02;C07D295/03;C07D295/18;C07D295/22;C07D401/04;C07D401/14;(IPC1-7):A61K31/495;A61K31/435 主分类号 C12Q1/02
代理机构 代理人
主权项
地址